The roughly 485 million packages that come into the U.S. duty free via the de minimis loophole is “overwhelming” and that volume “makes it harder for us to police products for consumer safety,” James Joholske, director of the office of import surveillance at the U.S. Consumer Product and Safety Commission (CPSC) told the U.S. China Economic and Security Review Commission on March 1
Roughly 40 congressional staff members had a chance to meet with and hear from industry leaders as diverse as Florida farmers to multinational corporations in the renewable energy space about the trials and tribulations of competing with emerging markets that play by different rules. And often break existing ones.
China’s predatory auto industry is a direct threat to American auto manufacturers and the hundreds of thousands of hard-working men and women that rely on this critical industry.
Coalition vice presidents explain the FDAs shortcomings and why U.S. medicines are often in short supply in a new American Affairs Journal article.
Last year, the U.S. imported more goods from Mexico than it did from China. It was a first. Although the trade deficit with China is still the biggest out of every country, and more than the trade deficit with Mexico and Canada combined, Mexican imports totaled $475.6 billion in 2023 versus China’s $427.2 billion.
The U.S. manufacturing boom, which started slowly since the implementation of tariffs on steel, aluminum, some China imports, and sped along by new laws favoring domestic supply chains, has had a positive impact on lower income counties nationwide.
An alarming new report from Horizon Advisory details China’s distortion of the global solar industry and how that threatens the national and economic security of the United States as it “risks making the United States dependent, and dependent on an adversary, for a strategic, future energy source.”
As imports from China rise, the native auto industry will whither at a time when a new auto industry is being born. Call it an opportunity lost.
The expert witness testimony made it clear that U.S. labs were treated differently than foreign ones, and despite increases in hiring at the FDA over the years, lawmakers have a lot to be concerned about when it comes to the FDA conducting proper oversight of foreign manufacturing facilities.
Chairman Gallagher and Ranking Member Krishnamoorthi’s bipartisan investigation is an alarming documentation of how American venture capital firms are investing billions into malign CCP companies.
